Dysregulated interleukin 6 expression produces a syndrome resembling Castleman's disease in mice.

Interleukin 6 (IL-6) is an important regulator of the acute phase response, T cell function, and terminal B cell differentiation. Excessive or inappropriate production of this cytokine may be involved in a variety of autoimmune and neoplastic disorders. To investigate the consequences of dysregulate...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Invest
Päätekijät:	Brandt, S J, Bodine, D M, Dunbar, C E, Nienhuis, A W
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Clinical Investigation 1990
Aiheet:	Research Article
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296765/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/2384605/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI114749
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!